Quality and Safety

Lack of integration with Brown and the affiliated teaching hospitals restricts economic development in Rhode Island, report finds.

Currently, Aduhelm, made by Biogen, is the only monoclonal antibody approved by the FDA for the treatment of Alzheimer's disease.

The current results stand in contrast to recent studies that found most mergers do not improve quality or safety.

CMS expects the changes to improve beneficiaries' experiences with MA and Part D, calling it a "higher standard" of benefits and health equity.

Mandate would cause massive economic shift as 1-3% of employees nationwide would quit, says Attorney Scott Keller.

This week's top stories include Elizabeth Holmes' conviction on three counts of wire fraud and one count of conspiracy to commit wire fraud by lying to investors, and jobs numbers that show healthcare is among the top three industries cited in the rise in monthly "quits rate."

The number of hospitalized COVID-19 patients has risen nearly 50% in the past week, according to Reuters data.

Motient can use workflows it derives from data to help providers get past the challenges of moving patients, according to company president Dallan Huff.

Existing pre-pandemic racial and ethnic disparities in hospital mortality widened during the pandemic, research has found.

The treatment has been cleared for anyone 12 years old and older who is at high risk for severe COVID-19, including hospitalization and death.